Policy and Regulatory Change Intelligence

Tracking the Rules, Policies, and Standards Shaping Regulated Industries

Regulatory requirements do not remain static. Congress passes legislation, FDA issues regulations and guidance, international standards evolve, and agency policies and programs change how regulated products are developed, manufactured, reviewed, and monitored.

MDP Policy & Regulatory Change Intelligence tracks these developments with an emphasis on what changed, who may be affected, when the change matters, and what regulated organizations should be considering next.

Legislation & Regulation

Federal legislation establishes much of FDA’s authority, while rulemaking translates statutory requirements into regulatory obligations. MDP follows significant legislation, proposed and final rules, implementation dates, and related policy developments affecting FDA-regulated industries.

FDA Guidance & Programs

FDA guidance documents provide critical insight into the agency’s current thinking and regulatory expectations. Agency initiatives and specialized programs can also significantly influence product development, review, manufacturing, compliance, and postmarket activities.

MDP monitors important new and revised guidance, FDA programs, policy announcements, and implementation developments across regulated product areas.

International Standards

International consensus standards play an increasingly important role in global regulatory compliance, particularly for medical devices and quality management systems.

MDP follows significant developments involving ISO, IEC, recognized consensus standards, harmonization initiatives, and changes in FDA recognition or use of standards that may affect regulatory strategy and compliance.

Implementation & Regulatory Impact

A new requirement is only the beginning. Organizations must determine when it takes effect, which products and operations are affected, what existing processes may need to change, and how regulators will apply the new expectations.

MDP connects regulatory developments with their implementation timelines, operational implications, compliance considerations, and potential impact on regulated organizations.

From Regulatory Change to Regulatory Intelligence

Knowing that a regulation, guidance document, law, or standard changed is useful. Understanding how the pieces interact and what organizations should be watching next is considerably more valuable.

MDP examines regulatory developments across agencies, requirements, standards, industries, and time to identify changing expectations, implementation challenges, emerging policy directions, and potential regulatory impact.

As the MDP Regulatory Intelligence program grows, this page will connect to regulatory change analyses, guidance updates, standards intelligence, implementation resources, timelines, and other policy research.

The change tells us what is different. Intelligence comes from understanding what it means.

Regulatory Intelligence

MDP integrates six interconnected areas into a comprehensive intelligence model.

Market Authorization Intelligence

Track what is entering the market and how regulatory pathways are evolving.

Enforcement Intelligence

FDA enforcement activity provides an important window into emerging compliance risks.

Inspections and Compliance

Inspection outcomes can reveal how regulatory expectations are being applied in practice.

Policy & Regulatory Change

We follow these developments with an emphasis on what changed, who is affected, when it matters, and what regulated organizations should be considering next.

Industry and Technology

Regulatory data can also reveal where innovation is occurring.